Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Operating Expenses | 12,823 | 12,637 | 12,909 | 12,763 | 11,637 |
| Operating Income | -12,823 | -12,637 | -12,909 | -12,763 | -11,637 |
| Other Income | 21 | 55 | -33 | -47 | 53 |
| Pre-tax Income | -12,802 | -12,582 | -12,942 | -12,810 | -11,584 |
| Income Tax | N/A | N/A | -2,273 | -5,812 | -355 |
| Net Income Continuous | -12,802 | -12,582 | -10,669 | -6,998 | -11,229 |
| Net Income Discontinuous | N/A | N/A | -46 | 12,099 | 848 |
| Net Income | $-12,802 | $-12,582 | $-10,715 | $5,101 | $-10,381 |
| EPS Basic Total Ops | -279.92 | -279.92 | -223.93 | 111.97 | -237.93 |
| EPS Basic Continuous Ops | -284.43 | -280.12 | -237.93 | -153.95 | -251.92 |
| EPS Basic Discontinuous Ops | N/A | N/A | 14.00 | 265.92 | 14.00 |
| EPS Diluted Total Ops | -279.92 | -279.92 | -223.93 | 111.97 | -237.93 |
| EPS Diluted Continuous Ops | -284.43 | -280.12 | -237.93 | -153.95 | -251.92 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 14.00 | 265.92 | 14.00 |
| EBITDA(a) | $-12,711 | $-12,487 | $-12,755 | $-12,580 | $-11,434 |